newsfilter
← Latest News
GlobeNewswire·

After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS

FDA stated that the "proposed data may be capable of supporting the submission and review of an [NDA] under the accelerated approval pathway" for CNM-Au8 based on neurofilament light (NfL) biomarker dataFDA acknowledged